XBRANE Xbrane Biopharma AB (publ)

1.021USD10.35 SEK · STO-2.82%Mkt Cap: 21.03M USDP/E: —

Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. It offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including…